Aphria Inc (fka APHA)

[john1311]

Medical cannabis trial will target 20,000 UK patients

Project backed by Royal College of Psychiatrists aims to be largest on drug’s use in Europe

Up to 20,000 patients in the UK are to be given medical cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe.

The move, to be unveiled on Thursday, is backed by one of the UK’s leading medical bodies and it is hoped it will persuade the NHS to prescribe the drug for a range of conditions.

Although medical cannabis was legalised in the UK a year ago, it remains unobtainable for many patients, according to campaigners.

“Medical cannabis is still out of reach for far too many,” said Professor David Nutt from the independent scientific body Drug Science, the organisation behind the launch of Project Twenty21, which will see 20,000 patients supplied with subsidised cannabis products by the end of 2021.

https://www.theguardian.com/society/2019/nov/03/medical-cannabis-uk-clinical-trial-patients-nhs